Recent Updates
Recently added Catalysts
RMD Positive Sentiment Score: 65/100

ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024

Key Takeaway: ResMed announced its plans to release financial and operational results for the third quarter of fiscal 2024 on April 25, 2024. The announcement follows a typical earnings release schedule, with management set to host a webcast to discuss these results. The webcast will also provide additional forward-looking information related to the company's performance and strategies. ResMed continues to focus on solutions that improve quality of life for patients with chronic diseases.

Market Sentiment Analysis

POSITIVE FACTORS

  • Scheduled earnings release suggests operational transparency.
  • Management will host a webcast to discuss financial results.
  • Highlights ResMed's commitment to innovating healthcare solutions.

Full Press Release Details

SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2024 on Thursday, April 25, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
• Location: http://investor.resmed.com
• Date: Thursday, April 25, 2024
• Time: 1:30 p.m. PDT / 4:30 p.m. EDT
• International: London, Thursday, April 25, 2024, 9:30 p.m. BST Sydney, Friday, April 26, 2024, 6:30 a.m. AEST
Please note, ResMed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from April 25, 2024, until May 9, 2024, at:
U.S.: +1 877.660.6853
International: +1 201.612.7415
Conference ID: 13745785
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

Frequently Asked Questions

When will ResMed announce Q3 2024 financial results?

ResMed will release its Q3 2024 results on April 25, 2024, after market close.

How can I access ResMed's earnings call?

The earnings call can be accessed via webcast at http://investor.resmed.com.

What time is the ResMed earnings webcast?

The earnings webcast is scheduled for 1:30 p.m. PDT on April 25, 2024.

Is there a replay available after the webcast?

Yes, a replay will be available on ResMed's website two hours after the webcast.

How long will the phone replay of the webcast be available?

The phone replay will be available from April 25 to May 9, 2024.

Last updated: Apr 4, 2024